Scleroderma, Diffuse: all 534 studies
Page 4 of 6. Open to participants first (115), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic SclerosisSuspendedNCT04166552Phase 2
- microRNAs in Systemic SclerodermaCompletedNCT04148716
- Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)WithdrawnNCT04138485Phase 2
- Muscular Respiratory Involvement and Systemic SclerosisCompletedNCT04118725Not applicable
- Vitamin D in Systemic Sclerosis Patients With PeriodontitisCompletedNCT04066842
- The Benefit of Bermekimab in Patients With Systemic SclerosisCompletedNCT04045743Phase 2
- RElevance of UltraSonography for Assessing Salivary Gland Involvement in Systemic Sclerosis (SSc)CompletedNCT04001556Not applicable
- The SPIN - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED)CompletedNCT03965780Not applicable
- Objective Measurement Methods for Autoimmune Disease and Dry Eye SyndromeWithdrawnNCT03937271
- SPIN Self-Management Feasibility TrialCompletedNCT03914781Not applicable
- A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic SclerosisCompletedNCT03889509
- Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017Status unknownNCT03858842
- Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung DiseaseStatus unknownNCT03856853Phase 3
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic SclerosisCompletedNCT03831438Phase 1
- Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)Status unknownNCT03819777
- A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisCompletedNCT03817424Phase 1
- A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic SclerosisCompletedNCT03766243Not applicable
- Cell Surface Marker Expression in Autoimmune DiseasesCompletedNCT03757065
- Local Injection of Ozone Versus Methylprednisolone Acetate in Carpal Tunnel Syndrome of Scleroderma PatientsCompletedNCT03742466Not applicable
- CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PHWithdrawnNCT03726398Phase 2/3
- Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic SclerosisCompletedNCT03717961Phase 3
- Prednisolone in Early Diffuse Systemic SclerosisCompletedNCT03708718Phase 2
- Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic SclerosisCompletedNCT03692299Phase 4
- Mycophenolate Mofetil Pharmacokinetics in Systemic SclerosisCompletedNCT03678987
- Suction Based Characterization of Healthy and Diseased SkinCompletedNCT03644225Not applicable
- BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIAStatus unknownNCT03629002
- Individualized Home-based Exercise Program for Patient With Systemic Sclerosis.CompletedNCT03614208Not applicable
- Pragmatic Clinical Trials in SclerodermaStatus unknownNCT03610217Not applicable
- Mechanisms of Pulmonary Diffusion Limitation in Systemic SclerosisCompletedNCT03601520
- The Small Intestine Bacterial Overgrowth Study PilotStatus unknownNCT03588845Not applicable
- Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic SclerosisCompletedNCT03561233Phase 1
- Evaluation of Effectiveness of Acetylsalicylic Acid on Markers of Vascular Dysfunction in Scleroderma PatientsCompletedNCT03558854Phase 4
- Professional and Personal Toxic Exposure in Systemic Sclerosis : Type, Intensity and Probability of ExpositionCompletedNCT03543956
- Analysis of Cytokine Expression Pattern in Systemic SclerosisCompletedNCT03537105Not applicable
- Topical Rosemary Oil Application in Systemic SclerosisCompletedNCT03531216Not applicable
- Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic SclerosisStatus unknownNCT03508375Not applicable
- Rehabilitation for Arm Coordination and Hand Movement in Systemic SclerosisCompletedNCT03482219Not applicable
- Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary HypertensionStatus unknownNCT03459716
- Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE)Status unknownNCT03446339
- Gut Microbiota Transplantation in Systemic SclerosisCompletedNCT03444220Phase 1/2
- Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILDCompletedNCT03438032
- Scleroderma Patient-centered Intervention Network (SPIN) Hand ProgramCompletedNCT03419208Not applicable
- Mindfulness Based Stress Reduction in Rheumatic DiseasesTerminatedNCT03411057
- Autologous Adipose Tissue in the Treatment of Systemic Sclerosis Digital UlcersStatus unknownNCT03406988Not applicable
- Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic SclerosisTerminatedNCT03398837Phase 3
- Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma DiseasesTerminatedNCT03388255Phase 4
- Neutrophil Extracellular Traps in Systemic SclerosisCompletedNCT03374618Not applicable
- A Pilot-Study of Sirolimus for the Treatment of Systemic SclerosisStatus unknownNCT03365869Phase 2
- Itch and Clinacal Caracteristics in Systemic SclerosisCompletedNCT03297580
- Transcutaneous Electroacupuncture for Gastric Complications of SclerodermaCompletedNCT03294616Not applicable
- Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble SwallowingWithdrawnNCT03270722Not applicable
- Role of Macrophage Migratory Inhibitory Factor in Systemic SclerosisStatus unknownNCT03268330
- Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural EnvironmentCompletedNCT03262922
- Health-related Quality of Life in Korean Patients With Rheumatic DiseasesStatus unknownNCT03257878
- Impact of Education and Training of Modified Rodnan Skin Scoring on the Reliability of TestStatus unknownNCT03219606Not applicable
- MRI Quantification of Pulmonary Fibrosis in Scleroderma PatientsCompletedNCT03207997Not applicable
- Brentuximab Vedotin in Early Diffuse Cutaneous Systemic SclerosisCompletedNCT03198689Phase 2
- Intraoperative ICG for Systemic SclerosisWithdrawnNCT03155464Phase 4
- Echo Systemic SclerosisStatus unknownNCT03143413
- The Effect of Ethanol Extract Physalis Angulata Linn. in Scleroderma Patients With Standard TherapyCompletedNCT03141125Not applicable
- Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept StudyCompletedNCT03120533Phase 1/2
- Pirfenidone as Treatment of Skin Fibrosis in Systemic SclerosisStatus unknownNCT03068234Phase 2/3
- The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )Status unknownNCT03059979Early Phase 1
- The Effects of Exercise in Patients With Systemic SclerosisCompletedNCT03058887Not applicable
- To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic SclerosisStatus unknownNCT03053739Phase 4
- Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary RaynaudCompletedNCT03027674Early Phase 1
- Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic SclerosisCompletedNCT03007004Phase 2
- ADMSCs for the Treatment of Systemic SclerosisCompletedNCT02975960Not applicable
- Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung DiseaseCompletedNCT02896205Phase 3
- The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)CompletedNCT02887495
- SCLERoderma et Adipose-DErived Stroma CellsStatus unknownNCT02866552Phase 2
- Duke Scleroderma Clinic Patient RegistryTerminatedNCT02851875
- Novel Rehabilitation Strategies to Improve Arm Function in Patients With SclerodermaCompletedNCT02837549Not applicable
- Optical Elastography of Systemic Sclerosis SkinCompletedNCT02835196
- Vocal Intervention in Systemic SclerosisStatus unknownNCT02821663Not applicable
- Seoul National University Hospital Systemic Sclerosis CohortStatus unknownNCT02819947
- FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMICStatus unknownNCT02808481
- Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital UlcersCompletedNCT02801305Phase 2
- Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis PatientsCompletedNCT02789670
- Obstructive Sleep Apnea in Scleroderma and Pulmonary InvolvementCompletedNCT02740569
- Ozone Therapy in the Treatment of Digital Ulcers in Patients With Systemic SclerosisCompletedNCT02733978Not applicable
- Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionActive, not recruitingNCT02682511Phase 2
- The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic SclerosisCompletedNCT02655640
- Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort StudyTerminatedNCT02642146
- A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)WithdrawnNCT02588625Phase 2
- Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic SclerosisTerminatedNCT02558543Phase 2
- CSL Behring Sclero XIIIStatus unknownNCT02551042Phase 2
- Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic SclerosisCompletedNCT02503644Phase 2
- The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic SclerosisCompletedNCT02480335Phase 4
- Light Treatment for Scleroderma Finger UlcersCompletedNCT02472743Not applicable
- Pregnancy and Medically Assisted Conception in Rare DiseasesWithdrawnNCT02450396
- Safety & Suitability of Dabigatran to Inhibit Thrombin in SclerodermaCompletedNCT02426229Phase 1
- Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)CompletedNCT02396238Not applicable
- A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy SubjectsCompletedNCT02386436Phase 1
- Oral Manifestations of Systemic SclerosisTerminatedNCT02371005Not applicable
- Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety TrialCompletedNCT02349009Phase 1/2
- Evaluating Pulmonary Arterial Hypertension in Patients With Systemic SclerosisWithdrawnNCT02339961Not applicable
- Treatment Outcome in Early Diffuse Cutaneous Systemic SclerosisCompletedNCT02339441
- Endothelial Microparticles in Systemic Sclerosis Pulmonary HypertensionCompletedNCT02331225